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Purpose: To screen ten genes for mutations in 32 Chinese patients with microphthalmia and/or coloboma.
Methods: Genomic DNA was prepared from 32 unrelated patients with microphthalmia (nine probands) and uveal
coloboma (23 probands). Cycle sequencing was used to detect sequence variations in ten genes, including BMP4, VSX2,
CRYBA4, GDF6, OTX2, RAX, SIX3, SIX6, SOX2, and LRP6. Variations were further evaluated in 96 unrelated controls
by using restriction fragment length polymorphism (RFLP) or heteroduplex-single strand conformation polymorphism
(HA-SSCP) analysis.
Results: In the ten genes, a novel c.751C>T (p.H251Y) in BMP4 was detected in a patient with bilateral microphthalmia
and unilateral cataract. The c.751C>T variation is also present in his healthy brother (and possibly one of the normal
parents). In addition, a novel c.608G>A (p.R203Q) in SIX6 was identified in an internal control for optimizing experimental
conditions. The internal control was from a girl with typical aniridia and an identified c.718C>T (p.R240X) mutation in
PAX6, suggesting the c.608G>A variation in SIX6 was unlikely to play a role in her ocular phenotype. The c.751C>T in
BMP4 and the c.608G>A in SIX6 were not present in the 96 normal controls. In addition, 16 nucleotide substitutions,
including eight known SNPs and eight new synonymous changes, were detected.
Conclusions: Although the genetic etiology for microphthalmia and/or coloboma is still elusive, rare variations in the
related genes, such as c.608 G>A in SIX6 and c.751C>T in BMP4, may not be causative. These results further emphasize
the importance of careful clinical and genetic analysis in making mutation-disease associations.
Microphthalmia and coloboma are important cause of
congenital blindness, with a prevalence at 1.9–3.5/10,000 live
births [1,2]. Microphthalmia and coloboma may be isolated
or syndromic with the extraocular phenotype in one or both
eyes.  The  disease  exhibits  diverse  patterns  of  genetic
inheritance, and the severity is variable, due to the genetic
heterogeneity of the ocular malformation [3-8]. Mutations in
several  genes  have  been  reported  in  patients  with
microphthalmia and/or coloboma [3,9-14], including BMP4
(OMIM 112262), VSX2 (CHX10; OMIM 142993), CRYBA4
(OMIM  123631),  OTX2  (OMIM  600037),  RAX  (OMIM
601881), SIX6 (OMIM 606326), and SOX2 (OMIM 184429).
Of  these,  mutations  in  SOX2  account  for  about  10%  of
microphthalmia,  anophthalmia,  and  coloboma  [3,15,16].
However, mutations in VSX2,CRYBA4,OTX2, and RAX have
been detected in about 2%–3% patients with microphthalmia,
anophthalmia, and coloboma [10,11,15,17,18]. Mutations in
SIX3 and GDF6 have been identified only in a few cases
[19,20]. Recently, mutations in BMP4 mutations have been
detected in patients with anophthalmia-microphthalmia [9].
In  addition,  knockout  of  LRP6  in  mice  resulted  in
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microphthalmia and coloboma, but has not yet been reported
in humans [21].
Because  most  of  these  genes  were  usually  studied
individually, and mutation analysis of Chinese patients is rare
so far, we screened 32 unrelated patients with microphthalmia
and/or coloboma for mutations in ten related genes, including
BMP4,  VSX2,  CRYBA4,  GDF6,  OTX2,  RAX,  SIX3,  SIX6,
SOX2, and LRP6, through sequencing analysis of the coding
and adjacent intronic regions of the ten genes.
METHODS
Patients  and  controls:  Thirty-two  unrelated  patients  were
recruited  from  our  Pediatric  and  Genetic  Eye  Clinic,
Zhongshan Ophthalmic Center. Clinical diagnoses of the 32
patients  were  microphthalmia  (nine  cases)  and  uveal
coloboma (23 cases). Diagnosis of microphthalmia was based
on  criteria  previously  described  [15],  that  is,  a  corneal
diameter less than 10 mm and an axial length less than 20 mm.
Of the nine cases with microphthalmia, eight met the criteria
but one did not, although a small cornea and short axial length
were recorded (details in results). On the other hand, the
inclusion criteria for uveal coloboma were 1) congenital cleft
in the inferior part of the iris and/or choroid (Figure 1) and 2)
exclusion of aniridia or macular uveal coloboma. Besides this,
an internal control sample for optimizing PCR and sequencing
conditions was from a girl with aniridia and an identified
PAX6  mutation.  Furthermore,  96  unrelated  controls  were
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2911collected from normal volunteers. A previously established
procedure  was  used  for  collecting  subjects  and  obtaining
informed  consent  [22].  This  study  was  approved  by  the
Institutional Review Board of Zhongshan Ophthalmic Center,
China. Genomic DNA was prepared from venous blood from
each participating individual [23].
Mutation detection: PCR was used to amplify the coding
exons  and  adjacent  intronic  sequences  of  the  ten  genes.
Reference sequences for the ten genes are listed in Table 1.
The primer sequences used to amplify the coding exons of the
ten  genes  are  listed  in  Table  2.  The  PCR  products  from
individual exons from each individual were sequenced with
the  ABI  BigDye  Terminator  cycle  sequencing  kit  v3.1
(Applied Biosystems, Foster City, CA) and an ABI 3100
Genetic Analyzer (Applied Biosystems). Sequencing results
and  consensus  sequences  from  the  NCBI  human  genome
database were compared by using the SeqManII program of
the Lasergene package (DNAstar Inc., Madison, WI). Each
mutation  was  confirmed  by  bidirectional  sequencing.
Mutation  description  followed  the  nomenclature
recommended by the Human Genomic Variation Society.
Heteroduplex-single  strand  conformation  polymorphism
analysis:  The  c.608G>A  variation  detected  in  SIX6  was
further  evaluated  in  96  normal  controls  by  heteroduplex-
single  strand  conformation  polymorphism  (HA-SSCP)
analysis, as previously described [24], using an extra pair of
primers (Table 2). Briefly, PCR products were mixed with an
equal volume of formamide dye loading buffer. Then 1–4 μl
Figure  1.  Uveal  coloboma.  A  and  B
demonstrate  iris  coloboma  (A)  and
choroid coloboma involving the optic
disc (B). C and D show inferior choroid
coloboma. (D did not align well with
C).
TABLE 1. GENOMIC INFORMATION OF THE 10 GENES REFERRED IN THIS STUDY.
Gene Genomic DNA mRNA Protein
BMP4 NC_000014.8 NM_001202.3 NP_001193.2
VSX2 NC_000014.8 NM_182894.2 NP_878314.1
CRYBA4 NC_000022.10 NM_001886.2 NP_001877.1
GDF6 NC_000008.10 NM_001001557.1 NP_001001557.1
OTX2 NC_000014.8 NM_021728.2 NP_068374.1
RAX NC_000018.9 NM_013435.2 NP_038463.2
SIX3 NC_000002.11 NM_005413.2 NP_005404.1
SIX6 NC_000014.8 NM_007374.2 NP_031400.2
SOX2 NC_000003.11 NM_003106.2 NP_003097.1
LRP6 NC_000012.11 NM_002336.2 NP_002327.2
The genomic DNA information was based on NCBI human genome build 36.3.
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2912TABLE 2. PRIMERS USED FOR POLYMERASE CHAIN REACTION AMPLIFICATION AND SEQUENCING OF BMP4, VSX2, CRYBA4, GDF6, OTX2, RAX, SIX3,
SIX6, SOX2, AND LRP6.





BMP4 3-F CCATCTTGCCCCTCCATTTCTA 570 65
  3-R CTTCTTCCCCAGGGCTTTCACT    
  4a-F TGCTTATTTTCCCCCAGTAGGT 704 62
  4a-R GGCGCCGGCAGTTCTTATTCTT    
  4b-F GGGCCAGCATGTCAGGATTAGC 575 62
  4b-R TGTGGGTGAGTGGATGGGAACG    
  RFLP-F CGGGAGAAGCAGCCAAACTATG 237 65
  RFLP-R CTTCTTCCTGGCCCGCTGTGAG    
VSX2 1-F AGGGGGCACCTGGGACCAAC 586 72
  1-R CCCGGCCTGGCAGGAACTTT    
  2-F CGGCGCGGGAGAGGTCAG 427 66
  2-R GCAGATTCCGCCAAACAAC    
  3-F TGCCCAGGAGACACAGAGG 347 64
  3-R ACATGATCATAGGCAAGCACA    
  4-F AGGACGCCCTGCTGGAGAAA 380 68
  4-R CCAAGTGCCCCTGCCTCAA    
  5-F CTGCGGTGTGGGGAGTAAG 574 65
  5-R GTGGGGAACAGGGAGGATG    
CRYBA4 2-F ACTCCTGGACTCCCTATGTG 319 60
  2-R ATTCAACCTCCCTGTATGTG    
  3-F TCTTGCCTTCCTGGCTCCTG 430 62
  3-R TGCGCAACCTGCATAATCTT    
  4-F CCCCTGAATGGTTGTGACT 396 62
  4-R AACCGAGGCTTGGAGAGGAA    
  5-F AAGGGCAAATGGCAAGGTT 415 62
  5-R TGGGCATCAGAGCACAAAAG    
GDF6 1-F GGCGGGGCCGGGGTTTGT 635 72
  1-R TAGCCTCCAGCGGGAACAGC    
  2a-F CGGCCGACCTGCCCCCACTC 504 70
  2a-R CCGGCCGAAGCCCAGACTCC    
  2b-F GCCGGCCGGCTGGGAAGTCT 557 70
  2b-R GCGAGCGCAGCGGGAAGTCG    
  2c-F GCGCACGGCCTTCGCCAGTC 469 70
  2c-R CCAGCGCCAGCTTCCTCCTC    
OTX2 3-F TTTGCTTTGCCCTTAGTTCC 424 62
  3-R CCCTGTTCTCTGCTTGGTCA    
  4-F ACGGTGGGGAGAGCATTGGT 445 62
  4-R CCTGGCCCCTTAGTGAGTGA    
  5a-F CTGCCCATGTAGGATAGATT 440 61
  5a-R ATGCCCCCAAAGTAGGAAGT    
  5b-F GCTTCCATCTCCCCACTGTC 562 61
  5b-R GGCCCTTCGTTTTTCCTTCT    
RAX 1-F TTCGCCCGCGGAGCTTGACCT 527 66
  1-R CCCCAACCCCGCGCCCAGTT    
  2-F CCATCGCCGCCCTCACCA 522 66
  2-R ACTCTGGGCATGCCAAGTCG    
  3-F TTGAGGGGGACGGAGTGGAG 716 69
  3-R GCAGGCGACAGGGAAAGAGG    
SIX3 1a-F TCATCGCCCCTCTCCTCCTCTT 398 70
  1a-R GCCGCTCGATGTCGCCCGTCTC    
  1b-F CGGCGGCGGCGGCTCCAG 387 72
  1b-R CGCACGCGGTACTTGTCCAC    
  1c-F GCGTGCGAGGCCATCAACAA 552 65
  1c-R CACGGCTTCCCTGGCTCTCA    
  2-F GCTCGGGTTCTGCCTCTC 457 64
  2-R TCGGTTTGTTCTGGGGATGG    
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SIX6 1a-F TGTGTCCCGCTGCCCCAATC 514 65
  1a-R TTCTGTTCGCCGTCCCAAATG    
  1b-F CCTTTCACGGTGGCAACTAC 514 65
  1b-R GACAGACCGCGCTCCCAACTC    
  2-F CGCCTTGCCGAGTAATCCT 447 70
  2-R AGCCCGCGGGTCCCTGGTCAC    
  HA-SSCP-F TCGCCTTAACTGCTGGGGTCTT 253 67
  HA-SSCP-R AGTGGCCGCCTTGCTGGATA    
SOX2 1-F CGCCTCCCCTCCTCCTCTC 443 68
  1-R CGCCGGGGCCGGTATTTAT    
  2-F GGGCGCCGAGTGGAAACTT 473 65
  2-R GGGTGCCCTGCTGCGAGTA    
  3-F CACGGCGCAGCGCAGATGC 459 65
  3-R TTTGCACCCCTCCCATTTC    
LRP6 1-F CTCCTCGCCTCCCCCACTTCTG 279 72
  1-R CTGCTCCCGGGCCCCTTTCTCT    
  2-F ATTTTCGACAGTCTTTGCTCAC 589 65
  2-R TTCTTTTCTCATAGGGGTCAGG    
  3-F GCGCGGCCTGAGCTTTCTTTA 410 64
  3-R CTTCTTCCCCTCTGGCACTTAG    
  4-F ATTTTAATGGGAGAGGTGACG 395 60
  4-R TTTATTCCCGCCAACTATCTTT    
  5-F AATTTTGGCTTATCACAGTT 330 58
  5-R GGTCTCCCAAAGCAGTAT    
  6-F TTTTATATTTATTTTTCAGTTC 575 50
  6-R ATGTTATCTTAGTCAATGTTTT    
  7-F GGGATGGATCTCACCTTTAG 478 58
  7-R GATCAGCAGCCATTTCTCA    
  8-F GGGGGAAAAGTGGTCAAA 538 56
  8-R GGGGGCAGTAAAGAAGGT    
  9-F TGGGAGCAAGACATAATCATAG 690 64
  9-R TGGCACGCACCTGTAGTCCT    
  10-F GGATCCTCTTGCCCCTGACA 560 62
  10-R TAACCCATTCCCCTCTTTCTTC    
  11-F ATTGTAGCCGTGATTTTGTTTA 577 58
  11-R TCAGGAGTATCTAGGGAGTTAT    
  12-F AAGCATGGGGTCAGAAGATAGA 777 62
  12-R AAAGTGCTGGGTTACGGACATA    
  13-F TGAGGGCATGCCAAAGAAT 499 58
  13-R AATAAGCTACCAGGTCCAGAAT    
  14-F GTGTGCCCATGTAGGTGTAAGC 511 64
  14-R TAGTGGCCCAGGAAAGAAAGTC    
  15-F CCGCCTCAGTCTCCCAAAGT 491 68
  15-R TGCCAAGAAATGTGCCAAAAAC    
  16-F TATCTAGTTTATTGGCTGTT 506 52
  16-R CTAAAAGTGCATGAAAGTCT    
  17-F AAGCTGATTATACATTTGATTT 403 64
  17-R GGGCAGGGTGGCAGAGAA    
  18-F TAAAGGAAGTAATGTGAAAACC 521 58
  18-R TGAAAAACCCCAACTGAC    
  19-F AGGCACCTTTTGATTCTTG 495 61
  19-R CGCCCGGCTGATTTCTATGTAT    
  20-F TTCAGGGCGTGGTATGTATGT 578 58
  20-R TATCTAAGGCCTTCTGTGTAAA    
  21-F AGCTATTCTTGGCCTTGTTCTA 508 61
  21-R AGTCCTTTGAGCCTTTTATGC    
  22-F TTTTAGCCATGATGAGGTCTTA 373 64
  22-R GGGGCTATATCAGGTCCACAAC    
  23-F GAAAATTGCCTCTTGGTCTGTG 550 65
  23-R TGGTCTGCCTCATCCTTCTCTA    
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2914of  the  mixture  was  loaded  on 40 cm×30  cm×1  mm  8%
polyacrylamide  gels  containing  10%  glycerol.  The  DNA
samples were separated by electrophoresis for 8–9 h at room
temperature  without  temperature  control.  The  DNA
fragments were visualized by silver staining.
Restriction  fragment-length  polymorphism  analysis:  The
variation detected in BMP4 c.751C>T was further evaluated
in available family members, as well as in 96 normal controls,
by  restriction  fragment-length  polymorphism  (RFLP)
analysis using an extra pair of primers (Table 2). Since the c.
751C>T variation in BMP4 erased an enzyme recognition site
of CviAII, wild amplicons were digested into four fragments
(78, 76, 68, and 15 bp) while the variant amplicons were cut
into three pieces (154, 68, and 15 bp).
RESULTS
Mutation analysis: Eighteen nucleotide substitutions (Table
3),  including  two  novel  missense  variations,  eight  known
SNPs, and eight new synonymous changes, were detected
upon complete sequencing analysis of the coding exons and
the  adjacent  intronic  regions  of  BMP4,  VSX2,  CRYBA4,
GDF6, OTX2, RAX, SIX3, SIX6, SOX2, and LRP6. Of the two
novel heterozygous missense variations, one was c.608G>A
(p.R203Q) in SIX6 and the other was c.751C>T (p.H251Y) in
BMP4.
For internal quality control, the c.608G>A variation in
SIX6 was detected in an individual when her sample was used
to optimize the experimental condition, but was not present in
96 unrelated normal controls. She was a three-month-old girl
who had typical congenital aniridia with normal cornea size
(a bilateral cornea diameter of 10 mm at the age of 3 months,
within  the  normal  range  at  this  age)  and  a  previously
determined novel PAX6 mutation (c.718C>T, p.R240X). This
suggested that the c.608G>A variation in SIX6 did not play
additive effect and, therefore, might not be causative.
The  c.751C>T  variation  in  BMP4  was  detected  in  a
proband suspected for microphthalmia (Figure 2), but was not
detected in 96 unrelated normal controls. BMP4 alignment
among six different species showed that the residue at 251 of
BMP4 protein is highly conserved (Figure 2C). This ocular
biometry  measurement  did  not  fully  meet  the  criteria  for
micropthalmia, but did demonstrate an obviously small cornea
and short axial length (Table 4). Besides this, he had bilateral
corneal  opacities,  multiple  pupils,  an  persistent  iris
membrane,  and  anterior  pole  cataract  (Figure  2D-E).
Unexpectedly, the c.751C>T variation was also present in his
healthy brother with a normal ocular phenotype, including a
normal anterior segment and normal axial length (Table 4 and
Figure 2F-G). His sister (II:1 in Figure 2) and parents (I:1 and
I:2  in  Figure  2)  were  reported  to  be  normal,  but  were
unavailable  to  have  ocular  biometry.  The  variation  was
present in both the proband and in his healthy brother, and at
least one of the parents (in whom only the proband had an
abnormal ocular phenotype).
TABLE 3. SEQUENCE VARIATIONS FOUND IN BMP4, CRYBA4, GDF6, LRP6, RAX, SIX3, SIX6, SOX2, AND VSX2.
Gene Exon Sequence variation
Amino acid
change Patient number Result
BMP4 4 c.455T>C S155S TT:TC:CC = 19:10:3 rs17563
  4 c.751C>T H251Y 1 Novel variation
CRYBA4 Intron 2 c.40-71C>T No splice site
change
2 rs2071860
  Intron 3 c.158+58C>T No splice site
change
3 rs58707060
  Intron 3 c.159-20A>G No splice site
change
AA:A/G:GG = 8:19:13 rs59023621
  Intron 5 c.444-18g>a No splice site
change
4  
GDF6 1 c.255G>T P85P 1  
LRP6 5 c.867C>T D289D 1  
  11 c.2450C>G S817C 1 rs2302686
  14 c.3184G>A V1062I 5 rs2302685
RAX 1 c.132C>A D44E 6 rs2271733
  3 c.882A>G Q294Q 4  
SIX3 1 c.90G>T A30A 4  
SIX6 1 c.421C>A N141K 7 rs33912345
  2 c.637C>T P213S 1  
  2 c.608G>A R203Q 1 Novel variation
SOX2 1 c.573A>G A191A 1  
VSX2 4 c.750G>A P250P 1  
No variation was identified in OTX2 .
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Normal development of the eye involves a complex process.
Both genetic and environmental factors may play roles in the
malformation of the eye. Although mutations in several genes
have  been  detected  in  patients  with  microphthalmia  or
coloboma,  such  mutations  are  only  detected  in  a  small
percentage of patients. In addition, these genes have not been
analyzed  simultaneously  in  any  cohort  of  microphthalmia
and/or coloboma cases.
In the present study, ten genes previously reported to be
responsible for microphthalmia and/or uveal coloboma were
analyzed  simultaneously  in  32  Chinese  patients  with
microphthalmia  and/or  uveal  coloboma.  Upon  complete
screening of the coding exons and adjacent intronic regions
of BMP4, VSX2, CRYBA4, GDF6, OTX2, RAX, SIX3, SIX6,
SOX2, and LRP6, no causative mutation was detected. This is
the  first  systemic  analysis  of  all  ten  genes  in  a  series  of
microphthalmia  and  coloboma  patients,  and  is  the  first
analysis of most such genes in Chinese patients. The results
suggest that the genetic cause of microphthalmia and uveal
coloboma in Chinese is largely unknown.
SIX6 encodes a nuclear homeoprotein and is expressed in
the developing retina, optic stalk, and the hypothalamic and
pituitary regions. Interstitial deletions at 14q22.3-q23, where
SIX6 is located, were found in three patients with bilateral
anophthalmia, absence of the optic nerve, and chiasm and
pituitary abnormalities [25]. Gallardo et al. [14] identified a
heterozygous c.493A>G (p.T165A) variation in SIX6 in a
Figure 2. BMP4 variation and associated
phenotype. A: Sequence chromatogram
demonstrated the c.751C>T variation in
BMP4 from the patient (left) and normal
sequence from a control (right). B: The
c.751C>T variation in BMP4 detected
by  PCR-RFLP  analysis  (P:  PCR
products  [237  bp]  and  M:  marker,
showing  100  bp  and  250  bp,
respectively; the plus sign [+] indicates
CviAII-digested-products  with
heterozygous  c.751C>T  variation;  the
minus sign [-] indicates CviAII-digested
products  without  the  c.751C>T
variation).  C:  Protein  alignment  of
human BMP4 (residues 231–271) with
other BMP4 orthologs from cattle, cock,
mouse,  rat,  and  zebra  fish.  D  and  E:
Ocular  phenotype  of  the  proband
showing bilateral microcornea, corneal
opacities, multiple pupils, persistent iris
membrane  adhering  to  cornea  (right
eye)  or  lens  capsule  (left  eye),  and
anterior pole cataract (right eye). F and
G:  Normal  ocular  phenotype  of  the
proband’s healthy brother, which also
carried  the  heterozygous  c.751C>T
variation in BMP4.










Proband OD 0.5 10.7 2.25 20.28
  OS 0.3 10.8 2.23 20.13
Healthy brother OD 1.5 11.4 3.39 22.78
  OS 1.5 11.6 3.32 22.74
Ocular biometry was measured by using IOL Master V5 (Carl Zeiss Meditec AG, Jena, Germany). The proband had a small
cornea  and short axial length. His brother had normal ocular biometry (normal range in Chinese adults: 12.12±0.40 mm for
cornea diameter and 23.60±0.79 mm for axial length).
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2916patient  with  bilateral  microphthalmia,  cataract,  and
nystagmus from among a series of 73 patients with syndromic
or  nonsyndromic  sporadic  clinical  anophthalmia  and
microphthalmia. However, this variation was also present in
the healthy father, although it was not detected in more than
160 chromosomes from normal individuals. Aijaz et al. [26]
did not find SIX6 mutation 173 patients with microphthalmia,
anophthalmia, and coloboma. In that study, the c.608G>A
variation in SIX6 was detected in an individual with typical
congenital  aniridia  and  a  previously  determined  PAX6
mutation  (c.718C>T,  p.R240X).  Overall,  there  is  no  firm
evidence  that  mutation  in  SIX6  alone  can  cause
microphthalmia, anophthalmia, or coloboma.
The  BMP4  gene  product  is  a  regulatory  molecule
functioning in mesoderm induction, tooth development, limb
formation,  bone  induction,  and  fracture  repair.  BMP4  is
located in 14q22-q23, where recurrent interstitial deletions
have been associated with anophthalmia-microphthalmia [9].
Bakrania  et  al.  [9]  identified  a  c.226del2  (p.S76fs104X)
mutation at BMP4 in a family whose carrier members had
various  phenotypes,  including  anophthalmia-
microphthalmia, retinal dystrophy, myopia, brain anomalies,
and polydactyly. In another family, a c.278A>G (p.E93G)
mutation was found. However, these two mutations were also
present in one of the phenotypically normal parents from each
family [9]. On the other hand, three missense mutations in
BMP4  were  reported  in  patients  with  orofacial  cleft  11
(OMIM 600625) [27]. In that study, the c.751C>T variation
in BMP4 was present in a patient with microphthalmia, as well
as in his healthy brother, and possibly in one of his normal
parents. Therefore, further study is needed to reveal the role
of BMP4 in micropthalmia.
In summary, the c.608G>A variation in SIX6 and the c.
751C>T variation in BMP4 might be reported as causative
mutations if the SIX6 c.608G>A variation is detected in a
patient without a confirmed genetic basis, and if cosegregation
analysis is not performed for the BMP4 c.751C>T variation.
Additional studies are expected to validate the association of
microphthalmia and uveal coloboma with mutations in SIX6
and BMP4. Great care is needed in making mutation–disease
associations based on marginal evidence, especially for those
genes with only a few identified mutations. Future genetic
analyses of additional patients, as well as of other candidate
genes, may enrich our understanding of the molecular basis
of microphthalmia and uveal coloboma, as well as of the
genotype–phenotype correlation.
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